NCT00935090Active, not recruiting
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET)
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This phase I trial is studying FLT PET imaging in patients with cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- First submitted
- 7 Jul 2009
- Start date
- Sept 2009
- Primary completion date
- 4 Apr 2024
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Diseases
- Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma, Amyloidosis, Myeloproliferative neoplasms, Follicular lymphoma, Hodgkin lymphoma, Chronic myeloid leukaemia, Myelodysplastic syndromes, Mantle cell lymphoma, Chronic lymphocytic leukaemia, Multiple myeloma, Acute myeloid leukemia
- NCT number
- NCT00935090
What you commit to
- Study type: Interventional
- From Sept 2009 to the primary completion date, 4 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- DISEASE CHARACTERISTICS:
- Meets one of the following criteria:
- Histologically confirmed solid tumor or hematologic malignancy
- Awaiting biopsy or surgery for cancer evaluation of a mass detected on exam or standard imaging
- PATIENT CHARACTERISTICS:
- Able to lie still in the PET scanner
- Girth and weight must be suitable to enter the gantry
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
- PRIOR CONCURRENT THERAPY:
- Not specified
Age in the registry: 18 years to 120 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Barbara Ann Karmanos Cancer Institute Coordinator of this site? Confirm its status | Detroit | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.